Is the risk of inflammatory bowel disease-related colorectal carcinoma limited?

Comment

. 2011 May;106(5):999; author reply 999-1000.

doi: 10.1038/ajg.2011.12.

Comment

Michael B Sprakes et al. Am J Gastroenterol. 2011 May.

. 2011 May;106(5):999; author reply 999-1000.

doi: 10.1038/ajg.2011.12.

No abstract available

Comment on

The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
Baars JE, Looman CW, Steyerberg EW, Beukers R, Tan AC, Weusten BL, Kuipers EJ, van der Woude CJ. Baars JE, et al. Am J Gastroenterol. 2011 Feb;106(2):319-28. doi: 10.1038/ajg.2010.428. Epub 2010 Nov 2. Am J Gastroenterol. 2011. PMID: 21045815

[Tracing colorectal carcinoma in patients with inflammatory bowel disease].
de Jong DJ, Nagengast FM. de Jong DJ, et al. Ned Tijdschr Geneeskd. 2007 Dec 15;151(50):2758-60. Ned Tijdschr Geneeskd. 2007. PMID: 18232192 Dutch.
[Epidemiology and natural history of chronic inflammatory bowel disease].
Lerebours E, Savoye G, Guedon C. Lerebours E, et al. Gastroenterol Clin Biol. 2003 Mar;27(3 Suppl):S76-80. Gastroenterol Clin Biol. 2003. PMID: 12704299 Review. French. No abstract available.
AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.
Farraye FA, Odze RD, Eaden J, Itzkowitz SH. Farraye FA, et al. Gastroenterology. 2010 Feb;138(2):746-74, 774.e1-4; quiz e12-3. doi: 10.1053/j.gastro.2009.12.035. Gastroenterology. 2010. PMID: 20141809 Review. No abstract available.
Inflammatory bowel disease-associated cancers: does gender change incidence?
Ullman TA. Ullman TA. Gastroenterology. 2010 May;138(5):1658-60. doi: 10.1053/j.gastro.2010.03.025. Epub 2010 Mar 21. Gastroenterology. 2010. PMID: 20332045 No abstract available.
Colorectal cancer in idiopathic inflammatory bowel disease.
Harpaz N, Talbot IC. Harpaz N, et al. Semin Diagn Pathol. 1996 Nov;13(4):339-57. Semin Diagn Pathol. 1996. PMID: 8946611 Review.